TriVascular Technologies (TRIV) Misses Q3 EPS by 6c

TriVascular Technologies (NASDAQ: TRIV) reported Q3 EPS of ($0.69), $0.06 worse than the analyst estimate of ($0.63). Revenue for the quarter came in at $7.88 million versus the consensus estimate of $7.9 million.

For earnings history and earnings-related data on TriVascular Technologies (TRIV) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Vivos Therapeutics posts 35% revenue gain but widens net loss